Public Health Preparedness: Developing and Acquiring Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Agents

“The anthrax attacks of 20001 and a radiation leak after the recent natural disaster of Japan highlighted concerns that the United States is vulnerable to threats from chemical, biological, radiological, and nuclear (CBRN) agents, which can cause widespread illness and death. GAO was asked to testify on the Department of Health and Human Services’ (HHS) CBRN medical countermeasure development and acquisition activities on …how HHS determines needed CBRN medical countermeasures and priorities for development and acquisition and selected agents to medical countermeasure development and acquisition.”

Author:
U.S. Government Accountability Office (GAO)
Publish Date:
2011